Medicine

Diagnostic Kit for Breast Cancer

• Model name : CK19(Cyfra21-1) & NSE Rapid Test
• One Step / Dual detection
• Point of care testing : Rapid test (20 minutes)
• High diagnostic rate (sensitivity: 97.1%, specificity: 86.9%] – diagnosis of the incipient cancer
• Diagnosis of small cell lung cancer and non-small cell lung cancer at the same time
• The first development of its kind in the world
• Certification of CE mark